Key Takeaways for 2026 Dental Practice Sales
-
The 2026 buyer pool for dental practices is segmented by revenue and EBITDA, with private dentists, DSOs, and hybrid aggregators each using different valuation methods and deal structures.
-
Private dentists are most active below $1.5M in collections, usually using SBA financing and paying 65–80% of collections, while DSOs and institutional buyers focus on larger practices and often use 5–13× EBITDA multiples.
-
Practices in the $1.5–3M revenue range can attract both private and DSO buyers, and the valuation gap between those paths can reach millions on the same practice.
-
Hybrid aggregators and regional roll-ups can provide flexible structures with higher cash-at-close percentages for owners who want partial liquidity without full corporate integration.
-
McLerran helps owners map their buyer pool and increase practice value potential, and you can book a free discovery call to review a preliminary value range.
How the Dental Practice Buyer Pool Works in 2026
The buyer pool for a dental practice is the set of qualified buyers who are likely to compete to purchase that specific practice. That pool can expand or contract based on annual collections, adjusted EBITDA, and operational factors such as provider mix, hygiene revenue, and payer composition.
Three primary buyer segments shape the 2026 market:
-
Private dentists (doctor-to-doctor buyers), who are individual dentists using SBA loans and are most active below $1.5M in collections.
-
DSOs and private-equity-backed groups, which are institutional buyers using EBITDA multiples and are most competitive once a practice reaches the $1M collections.
-
Hybrid aggregators and regional roll-ups, which are partnership-focused buyers targeting practices in the $300K–$1.5M EBITDA range with flexible, cash-heavy structures.
Revenue and EBITDA levels can be some of the main factors that determine which of these segments will engage seriously with a practice. Those levels also influence how much competitive tension an owner can create during a sale.
2026 Buyer Pool by Revenue: What to Expect at Each Level
The table below shows how buyer type, deal structure, and timeline often vary by revenue band in 2026. These figures come from current market data and should be viewed as directional ranges, not guarantees, because individual practice characteristics can shift outcomes within or beyond these bands.
|
Revenue Band (Collections) |
Typical Buyer Types |
Deal Structure |
Timeline |
|---|---|---|---|
|
Under $1M |
Private dentists (doctor-to-doctor), small DSO tuck-ins |
60–80% of trailing collections, SBA financing, 10–25% seller note |
90–150 days to close, 6–24 month seller transition |
|
$1M–$1.5M |
Private dentists, emerging and regional DSOs |
65–80% of collections (private), 5–6.5× EBITDA (DSO), 60–80% cash at close |
75–120 days (private), 45–90 days (DSO) |
|
$1.5M–$3M |
Regional DSOs, mid-tier DSO add-ons, private dentists (less common above $2M) |
6–9× EBITDA, 65–80% cash at close, 15–30% rollover equity, 5–15% earnout |
45–60 days (DSO auction), 3–5 year post-close commitment |
|
$3M+ |
Major DSOs, PE-backed platforms, hybrid aggregators |
7–13× EBITDA, 60–75% cash, 20–35% rollover equity, earnout |
45–90 days (structured auction), 3–5 year post-close commitment |
Private Dentist Buyers: Doctor-to-Doctor Sales
Individual dentists remain the main buyer type for practices below $1.5M in annual collections. These buyers usually rely on SBA 7(a) loans, which are federal small-business loans that allow dentists to borrow against goodwill and cash flow instead of only hard collateral.
Typical qualification thresholds for individual dentist buyers include:
-
A personal FICO credit score of 680 or higher, with 700+ often receiving better pricing
-
At least 2 years of clinical associate experience that shows consistent personal production
-
An active dental license in good standing with no disciplinary history
-
A target practice with a Debt Service Coverage Ratio (DSCR) of at least 1.25×, meaning the practice generates at least $1.25 in cash flow for every $1.00 of debt payment after paying the buyer a market-rate salary
SBA 7(a) loans are capped at $5M per borrower, which creates a practical ceiling on the size of practice an individual buyer can finance. For practices with $1M–$2M in collections, private dentists usually pay 65–80% of trailing 12-month collections. That pricing reflects the debt-service math of SBA financing rather than the EBITDA multiples that institutional buyers use.
Post-close transition periods for doctor-to-doctor sales usually run 6–24 months. During that time, the selling dentist works alongside the buyer to transfer patient relationships and practice knowledge. A walk-away sale, where the seller exits after a short 4–8 week work-back, can be realistic for single-doctor practices with strong systems and stable staff.
DSO and Private-Equity-Backed Group Buyers
DSOs and the private equity firms that support them use a different valuation approach than individual buyers. Instead of paying a percentage of collections, institutional buyers value practices on a multiple of normalized EBITDA, which is profitability after replacing the owner’s pay with a market-rate associate salary.
DSO buyers typically engage only when a practice meets or exceeds the $1M collections. Below that level, the DSO buyer pool becomes much thinner, and doctor-to-doctor sales often move more smoothly.
EBITDA multiple ranges by scale in 2026 can include:
-
Under $1M adjusted EBITDA: approximately 5–7×, usually as a small DSO tuck-in or add-on
-
$1M–$3M adjusted EBITDA: approximately 7–9×, often as a regional DSO add-on
-
$3M–$5M adjusted EBITDA: approximately 9–11×, often as an emerging platform
-
$5M+ adjusted EBITDA: 11× or higher, usually with platform-level private equity buyers
DSO deal structures for practices in the $1M+ collections range often include:
-
60–80% cash at close
-
20–40% rollover equity in the DSO platform, which usually remains illiquid until a second sale 5–7 years later
-
A 3–5 year post-close employment agreement at a market-rate associate compensation
-
An earnout tied to post-close EBITDA performance over 12–36 months
Because up to 40% of a DSO deal can be paid in equity instead of cash, the quality and financial strength of the acquiring DSO can be a major risk factor. Partnering with an undercapitalized or poorly run buyer can put a large share of the seller’s total proceeds at risk.
Hybrid Aggregators and Regional Roll-Ups
Hybrid aggregators and regional roll-ups sit between private buyers and large DSOs in the buyer pool. They are partnership-oriented buyers that focus on practices in the $300K–$1.5M EBITDA range within specific regions and often provide more flexible structures than national DSOs.
Key characteristics of this buyer segment include:
-
Higher cash-at-close percentages, often 70–80%, compared with many larger DSO buyers
-
Multiples in the 5–7× normalized EBITDA range
-
Partnership-style governance that can allow the selling dentist to retain more clinical autonomy than a full corporate affiliation
-
Suitability for owners who want partial liquidity and a meaningful payout while avoiding full integration into a large corporate infrastructure
Regional roll-ups can be appealing for practices that fall below the size that attracts major DSO interest but want more than a traditional doctor-to-doctor sale can provide. The trade-off is usually a lower headline multiple in exchange for more cash certainty and structural flexibility.
How Dental Practice Value Is Determined in 2026
Practice value in 2026 usually comes from 2 main methods, depending on buyer type and practice size:
-
Percentage of collections, which is common in doctor-to-doctor transactions where individual buyers typically pay 60–80% of trailing 12-month collections.
-
EBITDA multiple, which is standard for institutional buyers and is applied to normalized EBITDA after replacing owner compensation with a market-rate associate salary and adding back discretionary, personal, and non-recurring expenses.
The quality of the EBITDA analysis can be a major driver of value. Thorough identification and documentation of add-backs, which are legitimate expenses that inflate costs but do not reflect true operating costs, can shift both the multiple and the final price. Weak or incomplete analysis often gets challenged in due diligence, and buyers may attempt to lower the price. A diligence-grade, CPA-led analysis helps control the profitability story from the first buyer conversation.
Several factors can influence where a practice lands within a given multiple range. These can include hygiene revenue as a share of total production, provider concentration risk, payer mix, active patient count, and the strength of documented systems and infrastructure. Specialty also matters, since general dentistry, oral surgery, orthodontics, and pediatric dentistry can attract different levels of buyer demand and different multiple ranges, which vary by practice and market.
How to Sell a Dental Practice Quickly
Owners who want an efficient DSO transaction can often shorten the timeline to 45–60 days from going to market to signing a letter of intent (LOI) by using a structured, competitive bid process. Competition among multiple vetted buyers can speed decisions and shift negotiating leverage toward the seller.
McLerran & Associates runs a structured auction process that typically generates around 10 offers per listing. The process usually follows these steps:
-
A CPA-led EBITDA analysis and marketing deck are completed before going to market so the numbers are defensible from day one.
-
A virtual data room is built and shared with a vetted pool of pre-qualified buyers, and poorly run or undercapitalized buyers are screened out early.
-
Competitive bids are requested at the same time, which creates real tension among buyers.
-
The field narrows to the top one to three finalists for in-person meetings and final negotiations.
-
The LOI is negotiated on the seller’s behalf, covering price, cash at close, equity terms, and earnout provisions.
This approach produces a transaction rate of approximately 85–90% among McLerran & Associates’ clients. That rate compares with an industry norm closer to 35–40% and is much higher than the 15–20% close rate that many do-it-yourself sellers experience. The higher close rate reflects the combination of strong preparation, real buyer competition, and experienced advocacy throughout the process.
Frequently Asked Questions
What revenue qualifies my practice for DSO buyers versus private dentists?
Practices above $1.5M in collections usually attract more DSO competition, and those above $2M–$3M in collections can draw interest from larger regional and national platforms. These thresholds are directional, and specialty, location, EBITDA margin, and operational quality all influence which buyers will engage and how aggressively they will bid. A comprehensive valuation that maps value in both markets can provide the clearest picture.
How do deal structures differ across buyer segments?
Private dentist buyers usually finance acquisitions with SBA 7(a) loans, paying 65–80% of trailing collections with a seller note that covers 10–25% of the purchase price. The seller often works back 6–24 months to support the transition. DSO and private-equity-backed buyers use EBITDA multiples and structure deals as a mix of cash at close, usually 60–80%, rollover equity in the DSO platform, often 15–40%, and an earnout tied to post-close performance. Hybrid aggregators and regional roll-ups tend to offer higher cash-at-close percentages than large DSOs but lower headline multiples, with more flexible governance. The right structure depends on whether the owner prioritizes more cash now, more equity upside later, or a cleaner exit, and understanding the after-tax impact of each option can be helpful before choosing a path.
What financing do individual dentists use above $1M?
SBA 7(a) loans remain the main financing tool for individual dentist buyers acquiring practices valued above $1M. The program allows dentists to borrow against goodwill and cash flow, with loan amounts up to $5M. Qualification usually requires a personal credit score of 680 or higher, an active dental license in good standing, and a target practice with a DSCR of at least 1.25× after normalizing for a market-rate buyer salary. Specialty dental lenders, including practice finance divisions at major banks, underwrite most of these transactions and can often close in 60–90 days with as little as 10% down. The $5M SBA cap creates a practical ceiling on individual buyer capacity, which is one reason practices above $2M in collections more often transact with institutional buyers.
How does McLerran & Associates create competition among vetted buyers?
McLerran & Associates uses a structured, auction-style process that invites offers from multiple pre-qualified buyers at the same time instead of approaching them one by one. Before any buyer sees the practice, McLerran completes a diligence-grade EBITDA analysis and builds a detailed marketing deck and virtual data room. Buyers are vetted in advance, and poorly run or undercapitalized DSOs are excluded. As described earlier, this simultaneous approach typically produces around 10 competing offers, which creates real competitive tension that can improve both price and terms for the seller. The field then narrows to top finalists for in-person meetings. Because McLerran works both the private-buyer and DSO markets in roughly equal measure, it can run both pathways in parallel and provide a true side-by-side comparison. This process supports the 85–90% close rate mentioned earlier, compared with an industry norm closer to 35–40%.
Conclusion: Matching Your Practice to the Right Buyer Path
The buyer pool for dental practices in 2026 is segmented and competitive, and that structure can have a meaningful impact on outcomes. Private dentists, DSOs, and hybrid aggregators each use different valuation methods, deal structures, and post-close expectations, and the realistic set of buyers for any practice depends on where it falls on the collections and EBITDA spectrum.
Owners of strong practices generating $1M or more in annual revenue often have more options than in earlier market cycles. Capturing a strong outcome can depend on understanding the full landscape, running a competitive process among vetted buyers, and entering negotiations with a defensible, diligence-grade valuation that holds up under buyer review.
McLerran & Associates has guided more than 2,000 practice transitions and evaluated more than 10,000 practices over more than 35 years. The firm works both the private-buyer and DSO paths in approximately equal measure and uses a CPA-led EBITDA analysis, structured auction process, and vetted national buyer pool to help owners of premier practices pursue stronger outcomes.
Owners who are still weighing their options can attend the McLerran M&A Summit on October 29–30, 2026, a dental-only event designed for undecided owners. Attendees receive 4 CE credits and a complimentary practice valuation, which is typically a $2,500 service.
